330889770	330889770	CD	B-NP	O
|	|	NN	I-NP	O
ALUH	ALUH	NN	I-NP	O
|	|	NN	I-NP	O
57771309	57771309	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7357464	7357464	CD	B-NP	O
|	|	CC	I-NP	O
11/28/2005	11/28/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
VENTRICULAR	VENTRICULAR	NNP	I-NP	I-protein
FIBRILLATION	FIBRILLATION	NNP	I-NP	I-protein
ARREST	ARREST	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/10/2005	2/10/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/17/2005	1/17/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MARVIN	MARVIN	NNP	B-NP	O
,	,	,	O	O
KERMIT	KERMIT	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Orlikowski	Orlikowski	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
54-year-old	54-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
long	long	JJ	B-NP	O
QT	QT	NN	I-NP	O
interval	interval	NN	I-NP	O
,	,	,	O	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
changes	change	NNS	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
following	follow	VBG	I-VP	O
cardiac	cardiac	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
appointment	appointment	NN	I-NP	O
at	at	IN	B-PP	O
Irun	Irun	NNP	B-NP	O
Adi	Adi	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
2/20/05	2/20/05	CD	B-NP	O
where	where	WRB	B-ADVP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
dialysis	dialysis	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
noted	note	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
feel	feel	VB	I-VP	O
strange	strange	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
questionable	questionable	JJ	I-NP	O
seizure	seizure	NN	I-NP	O
earlier	earlier	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
per	per	IN	B-PP	O
history	history	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
dialysis	dialysis	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
became	become	VBD	B-VP	O
increasingly	increasingly	RB	B-ADJP	O
confused	confuse	VBN	I-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Sidecoa	Sidecoa	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
Cleavexo	Cleavexo	NNP	I-NP	O
Brock	Brock	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
ED	ED	NNP	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
tachycardia	tachycardia	NNS	B-NP	O
going	go	VBG	B-VP	O
in	in	RB	B-ADVP	O
to	to	TO	B-VP	O
torsade	torsade	VB	I-VP	O
de	de	FW	B-NP	O
pointes	pointes	FW	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
DC	DC	NN	I-NP	B-cell_type
cardioversion	cardioversion	NN	I-NP	O
shock	shock	NN	I-NP	O
at	at	IN	B-PP	O
200	200	CD	B-NP	O
joules	joule	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
intubated	intubate	VBN	I-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
coded	cod	VBN	I-VP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
report	report	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developing	develop	VBG	B-VP	O
a	a	DT	B-NP	O
tonic-clonic	tonic-clonic	JJ	I-NP	O
seizure	seizure	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
bagging	bagging	NN	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
intubation	intubation	NN	B-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
this	this	DT	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
EKG	EKG	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
QT	QT	NN	I-NP	O
interval	interval	NN	I-NP	O
of	of	IN	B-PP	O
540	540	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
is	be	VBZ	B-VP	O
apparently	apparently	RB	B-ADVP	O
around	around	IN	B-NP	O
510	510	CD	I-NP	O
milliseconds	millisecond	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
were	be	VBD	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
3.7	3.7	CD	B-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
magnesium	magnesium	NN	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
phosphate	phosphate	NN	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
0.9	0.9	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
elevated	elevated	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Centrah	Centrah	NNP	I-NP	O
Steadmot	Steadmot	NNP	I-NP	O
Ain	Ain	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
workup	workup	NN	I-NP	O
and	and	CC	I-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
arrival	arrival	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
,	,	,	O	O
sedated	sedate	VBN	B-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

End-stage	End-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
non-ST	non-ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
6/29	6/29	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

A	A	DT	B-NP	O
long	long	JJ	I-NP	O
QT	QT	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Seizure	Seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Alcoholic	Alcoholic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
gastritis	gastritis	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
changes	change	NNS	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
ICP	ICP	NN	I-NP	B-protein
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Penile	Penile	JJ	B-NP	O
amputation	amputation	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
infected	infected	JJ	B-NP	O
implant	implant	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Hep	Hep	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
hep	hep	NN	B-NP	O
C	C	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Tetracycline	Tetracycline	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
240/79	240/79	CD	B-NP	O
and	and	CC	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
72	72	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
on	on	IN	B-PP	O
arrival	arrival	NN	B-NP	O
on	on	IN	B-PP	O
assist-control	assist-control	JJ	B-NP	O
volume	volume	NN	I-NP	O
setting	set	VBG	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
tidal	tidal	JJ	I-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
500	500	CD	B-NP	O
mL	mL	NN	I-NP	O
,	,	,	O	O
12	12	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
saturating	saturate	VBG	I-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
mechanical	mechanical	JJ	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	I-NP	O
rhonchi	rhonchus	NNS	I-NP	O
or	or	CC	I-NP	O
rales	rale	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
2/6	2/6	CD	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBD	B-VP	O
loudest	loud	JJS	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
distally	distally	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Extremity	Extremity	NN	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
leg	leg	NN	B-NP	O
below-the-knee	below-the-knee	JJ	I-NP	O
amputation	amputation	NN	I-NP	O
.	.	.	O	O

Neurologically	Neurologically	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
unresponsive	unresponsive	JJ	B-ADJP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
sedation	sedation	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
move	move	VB	I-VP	O
all	all	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
sedation	sedation	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
responded	respond	VBN	I-VP	O
?	?	.	O	O
?	?	.	O	O
_____	_____	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
purposefully	purposefully	RB	B-ADVP	O
to	to	TO	B-VP	O
pain	pain	VB	I-VP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Torsade	Torsade	FW	B-NP	O
de	de	FW	I-NP	O
pointes	pointes	FW	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
DC	DC	NN	I-NP	O
cardioversion	cardioversion	NN	I-NP	O
:	:	:	O	O
Given	Give	VBN	B-VP	O
his	his	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
torsade	torsade	FW	B-NP	O
de	de	FW	I-NP	O
pointes	pointes	FW	I-NP	O
requiring	require	VBG	I-NP	O
cardioversion	cardioversion	NN	I-NP	O
,	,	,	O	O
upon	upon	IN	B-PP	O
presentation	presentation	NN	B-NP	O
to	to	TO	B-PP	O
Neysing	Neysing	NNP	B-NP	O
Areid	Areid	NNP	I-NP	O
Risbanks	Risbanks	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Mazikowski	Mazikowski	NNP	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
vigorously	vigorously	RB	I-VP	O
repleted	replete	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
presentation	presentation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
prolonged	prolonged	JJ	I-NP	O
QT	QT	NN	I-NP	O
interval	interval	NN	I-NP	O
and	and	CC	O	O
therefore	therefore	RB	B-VP	O
medicated	medicate	VBN	I-VP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
exacerbate	exacerbate	VB	I-VP	O
his	his	PRP$	B-NP	B-DNA
already	already	RB	I-NP	O
long	long	JJ	I-NP	O
QT	QT	NN	I-NP	O
interval	interval	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
Celexa	Celexa	NN	I-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
.	.	.	O	O

Throughout	Throughout	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Gift	Gift	NNP	I-NP	O
was	be	VBD	B-VP	O
closely	closely	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
via	via	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
events	event	NNS	I-NP	O
of	of	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
When	When	WRB	B-ADVP	O
he	he	PRP	B-NP	O
presented	present	VBD	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	O	O
also	also	RB	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
Plavix	Plavix	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
7/24/05	7/24/05	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
proximal	proximal	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ramus	ramus	NN	I-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
marginal	marginal	JJ	I-NP	O
1	1	CD	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
.	.	.	O	O

None	None	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
were	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
caused	cause	VBN	I-VP	O
his	his	PRP$	B-NP	O
ischemia	ischemia	NN	I-NP	O
such	such	IN	B-PP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
would	would	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
the	the	DT	B-NP	O
etiological	etiological	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
torsades	torsade	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Electrophysiology	Electrophysiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
:	:	:	O	O
While	While	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
severe	severe	JJ	B-NP	O
concentric	concentric	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vigorous	vigorous	JJ	B-NP	O
after-load	after-load	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
Lopressor	Lopressor	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
Norvasc	Norvasc	NN	B-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hydralazine	hydralazine	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

End-stage	End-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
repeat	repeat	NN	I-NP	O
dialysis	dialysis	NN	I-NP	O
with	with	IN	B-PP	O
close	close	JJ	B-ADJP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Renal	Renal	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
regular	regular	JJ	B-NP	O
dialysis	dialysis	NN	I-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
Apseph	Apseph	NNP	B-NP	O
's	's	POS	B-NP	O
Danale	Danale	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
repleted	replete	VBN	B-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Seizure	Seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
was	be	VBD	B-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
tonic-clonic	tonic-clonic	JJ	I-NP	O
seizure	seizure	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
Keppra	Keppra	NNP	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
seizure-free	seizure-free	JJ	B-ADJP	O
while	while	IN	B-SBAR	O
hospitalized	hospitalize	VBN	B-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
markedly	markedly	RB	B-NP	O
labile	labile	JJ	I-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Portland	Portland	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
tight	tight	JJ	B-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Endocrine	Endocrine	NNP	I-NP	O
Team	Team	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
recommended	recommend	VBD	B-VP	O
switch	switch	NN	B-NP	O
to	to	TO	B-PP	O
Lantus	Lantus	NNP	B-NP	O
for	for	IN	B-PP	O
basal	basal	JJ	B-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
glucose	glucose	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
attain	attain	VB	I-VP	O
appropriate	appropriate	JJ	B-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
for	for	IN	B-PP	O
nutrition	nutrition	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
NG	NG	NN	I-NP	B-DNA
tube	tube	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	B-DNA
altered	alter	VBN	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
agitations	agitation	NNS	B-NP	O
,	,	,	O	O
during	during	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
pulled	pull	VBD	B-VP	O
out	out	RP	B-PRT	O
his	his	PRP$	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
trialed	triale	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
soft	soft	JJ	I-NP	O
diet	diet	NN	I-NP	O
after	after	IN	B-PP	O
consultation	consultation	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Speech	Speech	NNP	I-NP	O
and	and	CC	I-NP	O
Swallow	Swallow	NNP	I-NP	O
Service	Service	NNP	I-NP	O
on	on	IN	B-PP	O
2/1	2/1	CD	B-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
these	these	DT	B-NP	O
p.o.	p.o.	FW	I-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
diet	diet	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

COMPLICATIONS	COMPLICATIONS	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

CONSULTANTS	CONSULTANTS	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Electrophysiology	Electrophysiology	NNP	B-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	NNP	B-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrinology	Endocrinology	NNP	B-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Speech	Speech	NN	B-NP	O
and	and	CC	I-NP	O
Swallow	Swallow	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	VBP	B-VP	O
THAT	THAT	NN	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
headache	headache	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
folic	folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	B-protein
5000	5000	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
to	to	TO	B-VP	O
be	be	VB	I-VP	O
injected	inject	VBN	I-VP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
immobilized	immobilize	VBN	I-VP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
every	every	DT	B-NP	O
meal	meal	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
if	if	IN	B-SBAR	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
90	90	CD	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
is	be	VBZ	B-VP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
100	100	CD	I-NP	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
55	55	CD	I-NP	O
,	,	,	O	O
nystatin	nystatin	NN	B-NP	B-protein
mouthwash	mouthwash	NN	I-NP	I-protein
500	500	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
,	,	,	O	O
Keppra	Keppra	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
insulin	insulin	NN	I-NP	B-protein
10	10	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
once	once	RB	B-ADJP	O
daily	daily	JJ	I-ADJP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Nephrocaps	Nephrocap	VBZ	B-VP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
cachetic	cachetic	JJ	B-ADJP	O
appearing	appear	VBG	B-VP	O
male	male	JJ	B-ADJP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
exam	exam	NN	I-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
coarse	coarse	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Upper	Upp	JJR	B-NP	O
airways	airway	NNS	I-NP	O
sounds	sound	NNS	I-NP	O
are	be	VBP	B-VP	O
prominent	prominent	JJ	B-ADJP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
sounds	sound	NNS	I-NP	O
are	be	VBP	B-VP	O
distant	distant	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
loudest	loud	JJS	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
noted	note	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
epigastrium	epigastrium	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
rebound	rebound	NN	I-NP	O
or	or	CC	I-NP	O
guarding	guarding	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremity	extremity	NN	I-NP	O
exam	exam	NN	I-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
above-the-knee	above-the-knee	JJ	B-NP	O
amputation	amputation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Endocrinology	Endocrinology	NNP	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
his	his	PRP$	B-NP	O
dialysis	dialysis	NN	I-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-4140501	7-4140501	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MCCUTCHEON	MCCUTCHEON	NNP	B-NP	O
,	,	,	O	O
LUTHER	LUTHER	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ALMADA	ALMADA	NNP	B-NP	O
,	,	,	O	O
JEFFERSON	JEFFERSON	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7629538	7629538	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/5/05	1/5/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/5/05	1/5/05	CD	B-NP	O

